Key result
Accelerated aging on pulse-waveform clocks is linked to ~87% higher CVD odds.
Why the study?
Aging alters photoplethysmography and arterial blood pressure waveform morphology, motivating investigation into whether the discrepancy between waveform-predicted and chronological age could serve as a measure of cardiovascular health.
Does an aging clock derived from photoplethysmography and arterial blood pressure waveform features associate with cardiovascular disease in surgical patients?
Observational (n=17,327)
Does an aging clock derived from photoplethysmography and arterial blood pressure waveform features associate with cardiovascular disease in surgical patients?
Machine learning aging clocks based on photoplethysmography and arterial blood pressure waveform features accurately predict age and serve as novel biomarkers associated with the odds of cardiovascular disease.
Answers are grounded in this paper and cite their sources.
Accelerated PPG aging signals warrant no practice change; leaves open value for CVD risk prediction pending validation.
Aging affects the morphology of photoplethysmography (PPG) and arterial blood pressure (ABP) waveforms. Here, we demonstrate that machine learning (ML) models trained on features derived from PPG or ABP waveforms can predict an individual's age. We further investigated whether the discrepancy between predicted and chronological age (Age-Gap) could serve as a measure of cardiovascular health by testing its association with cardiovascular disease (CVD). From a large perioperative dataset of 17,327 surgical patients, high-fidelity PPG and ABP waveforms were analyzed, and over 840 time-, frequency-, and statistical-domain features per cardiac cycle were extracted using a signal-processing-based tool. These features were then used to develop ML-based aging clocks, PPGAge and ABPAge, trained on PPG and ABP features, respectively. For each aging clock, we evaluated five ML models: Light Gradient Boosting Machine (LightGBM), eXtreme Gradient Boosting (XGBoost), Random Forest, Lasso, and Elastic Net. Individuals were classified as having accelerated, normal, or delayed aging based on their Age-Gap relative to the model-specific mean absolute error (MAE, rounded up to the nearest whole year): accelerated aging was defined as Age-Gap ≥ +MAE, normal aging as −MAE ≤ Age-Gap < +MAE, and delayed aging as Age-Gap < −MAE. LightGBM provided the best age predictions for both aging clocks, with Pearson correlation coefficients (r) of 0.92 and 0.92 and R-squared values of 0.81 and 0.82 for PPGAge and ABPAge, respectively. Moreover, we found that accelerated aging was significantly associated with higher odds of CVD for both aging clocks, PPGAge (odds ratio, 1.87 [95% CI, 1.59-2.21], p<0.001) and ABPAge (odds ratio, 2.28 [95% CI, 1.51-3.43], p<0.001). Additionally, delayed aging was significantly associated with lower odds of CVD for PPGAge (odds ratio, 0.68 [95% CI, 0.58-0.80], p<0.001). Our findings suggest that aging clocks based on high-fidelity PPG or ABP waveform features may serve as novel biomarkers for identifying individuals with higher odds of CVD.
No takes yet. Share an insight, caveat, or question.
Pal et al. (2026) conducted an observational in Cardiovascular disease (n=17,327). Accelerated aging via ML-based physiological waveform aging clocks (PPGAge and ABPAge) vs. Normal aging (−MAE ≤ Age-Gap < +MAE) was evaluated on Cardiovascular disease (CVD) (OR 1.87, 95% CI 1.59-2.21, p=<0.001). Accelerated aging via PPGAge and ABPAge clocks was associated with higher odds of CVD.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: